Weihe Zhang
University of North Carolina at Chapel Hill(US)Capital Medical University(CN)Beijing Chest Hospital(CN)BioCryst Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Phagocytosis and Immune Regulation, Cancer, Hypoxia, and Metabolism, Metabolism, Diabetes, and Cancer, Cell death mechanisms and regulation, Cancer-related Molecular Pathways
Most-Cited Works
- → A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo(2012)551 cited
- → UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor(2014)159 cited
- → MERTK receptor tyrosine kinase is a therapeutic target in melanoma(2013)144 cited
- → Total Synthesis of Absinthin(2004)104 cited
- → Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms(2010)88 cited
- → The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia(2016)78 cited